Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban

Am J Hematol. 2017 Jan;92(1):E9-E10. doi: 10.1002/ajh.24588. Epub 2016 Nov 22.

Authors

Eva S Laube¹, Simon Mantha¹, Patrick Samedy², Jonathan Wills³, Stephen Harnicar⁴, Gerald A Soff¹

Affiliations

¹ Hematology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
² Division of Quality and Safety, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Data Solution Group, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Pharmacy Department, Memorial Sloan Kettering Cancer Center, New York, New York.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Male
Middle Aged
Neoplasms / therapy*
Retrospective Studies
Rivaroxaban / administration & dosage*
Upper Extremity Deep Vein Thrombosis / drug therapy*

Substances

Rivaroxaban